Comparison of Health Care Utilization by Medicare Advantage and Traditional Medicare Beneficiaries With Complex Care Needs.


Journal

JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500

Informations de publication

Date de publication:
07 10 2022
Historique:
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

Medicare beneficiaries with co-occurring chronic conditions and complex care needs experience high rates of acute care utilization and poor outcomes. These patterns are well described among traditional Medicare (TM) beneficiaries, but less is known about outcomes among Medicare Advantage (MA) beneficiaries. Compared with TM, MA plans have additional levers to potentially address beneficiary needs, such as network design, care management, supplemental benefits, and value-based contracting. To compare health care utilization for MA and TM beneficiaries with complex care needs. This cross-sectional study analyzed beneficiaries enrolled in MA and TM using claims data from a large, national MA insurer and a random 5% sample of TM beneficiaries. Beneficiaries were segmented into the following cohorts: frail elderly, major complex chronic, and minor complex chronic. Regression models estimated the association between MA enrollment and health care utilization in 2018, using inverse probability of treatment weighting to balance the MA and TM cohorts on observable characteristics. The study period was January 1, 2017, through December 31, 2018. All analyses were conducted from December 2020 to August 2022. Enrollment in MA vs TM. Hospital stays (inpatient admissions and observation stays), emergency department (ED) visits, and 30-day readmissions. Among a study population of 1 844 326 Medicare beneficiaries (mean [SD] age, 75.6 [7.1] years; 1 021 479 [55.4%] women; 1 524 458 [82.7%] White; 223 377 [12.1%] with Medicare-Medicaid dual eligibility), 1 177 896 (63.9%) were enrolled in MA and 666 430 (36.1%) in TM. Beneficiary distribution across cohorts was as follows: frail elderly, 116 047 with MA (10.0% of the MA sample) and 104 036 with TM (15.6% of the TM sample); major complex chronic, 320 954 (27.2%) and 158 811 (23.8%), respectively; and minor complex chronic, 740 895 (62.9%) and 403 583 (60.6%), respectively. Beneficiaries enrolled in MA had lower rates of hospital stays, ED visits, and 30-day readmissions. The largest relative differences were observed for hospital stays, which ranged from -9.3% (95% CI, -10.9% to -7.7%) for the frail elderly cohort to -11.9% (95% CI, -13.2% to -10.7%) for the major complex chronic cohort. In this cross-sectional study of Medicare beneficiaries with complex care needs, those enrolled in MA had lower rates of hospital stays, ED visits, and 30-day readmissions than similar beneficiaries enrolled in TM, suggesting that managed care activities in MA may influence the nature and quality of care provided to these beneficiaries.

Identifiants

pubmed: 36206006
pii: 2797081
doi: 10.1001/jamahealthforum.2022.3451
pmc: PMC9547312
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e223451

Références

Am Econ J Appl Econ. 2019 Apr;11(2):302-332
pubmed: 31131073
J Gerontol A Biol Sci Med Sci. 2021 Jun 14;76(7):1316-1317
pubmed: 32529241
Health Serv Res. 2022 Aug;57(4):863-871
pubmed: 35156205
J Polit Econ. 2020 Mar;12(3):984-1026
pubmed: 32719571
Health Aff (Millwood). 2021 Jun;40(6):937-944
pubmed: 34097516
Am J Manag Care. 2010 Jul 01;16(7):e157-62
pubmed: 20645661
Health Aff (Millwood). 2017 Dec;36(12):2085-2093
pubmed: 29200328
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
JAMA. 2009 Feb 11;301(6):603-18
pubmed: 19211468
Ann Intern Med. 2017 Nov 21;167(10):706-713
pubmed: 29049488
Health Aff (Millwood). 2020 Sep;39(9):1486-1494
pubmed: 32897788
JAMA Netw Open. 2019 Jul 3;2(7):e196939
pubmed: 31298714
Healthc (Amst). 2017 Mar;5(1-2):62-67
pubmed: 27914968
Am J Manag Care. 2021 Sep;27(9):395-400
pubmed: 34533909
JAMA Netw Open. 2020 Mar 2;3(3):e201809
pubmed: 32227181
Health Serv Res. 2017 Aug;52(4):1264-1276
pubmed: 28726238
Health Aff (Millwood). 2012 Jan;31(1):110-9
pubmed: 22232101
Health Aff (Millwood). 2019 Jan;38(1):107-114
pubmed: 30615516
J Gen Intern Med. 2021 Dec;36(12):3891-3893
pubmed: 32869199
Med Care. 2020 Nov;58(11):1004-1012
pubmed: 32925471

Auteurs

Dana Drzayich Antol (D)

Humana Healthcare Research, Louisville, Kentucky.

Richard Schwartz (R)

Humana Inc, Louisville, Kentucky.

Ariel Caplan (A)

Humana Inc, Louisville, Kentucky.

Adrianne Casebeer (A)

Humana Inc, Louisville, Kentucky.

C Jo Erwin (CJ)

Humana Inc, Louisville, Kentucky.

William H Shrank (WH)

Humana Inc, Louisville, Kentucky.

Brian W Powers (BW)

Humana Inc, Louisville, Kentucky.
Mass General Brigham, Boston, Massachusetts.
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH